Oral Solid Dosage Manufacturing Market - Distribution by Type of Finished Dosage Form, Type of Packaging, Scale of Operation, Company Size, Therapeutic Area, and Key Geographical Regions: Industry ...

Scale-up of the CDMO segment in FY26, is expected to contribute meaningfully to revenue growth and margin expansion, aided by ...

Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form, and Key Geographies: Industry ...

Hikma has completed its acquisition of Xellia Pharmaceuticals’ U.S. finished dosage form business and related assets following clearance under applicable U.S. antitrust laws.

(RTTNews) - Hikma Pharmaceuticals (HIK, HIK.L) has agreed with Xellia Pharmaceuticals to acquire parts of its US finished dosage form business and assets, including a commercial portfolio and ...

Laurus Labs shares rose over 2% in Monday's trading, marking three days of gains. In June 2025, the stock has gained 18%, ...

Laurus Labs pharma stock jumps 23 per cent in one month on strong CDMO growth, FY25 earnings, and margin expansion.

DUBLIN--(BUSINESS WIRE)--The "Oral Solid Dosage Manufacturing Market - Distribution by Type of Finished Dosage Form, Type of Packaging, Scale of Operation, Company Size, Therapeutic Area, and Key ...